In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
NEW YORK (Reuters Health) – A South African study shows that HIV-infected patients do better when they begin treatment above rather than below 200 cells/µL. The results, reported…
NEW YORK (Reuters Health) – Results of primary percutaneous intervention (PCI) in patients with ST-segment elevation MI are better when the procedure is performed via the radial artery…
NEW YORK (Reuters Health) – According to a new report, primary care patients who may have a drug use disorder can be reliably identified with a single-question screening…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
NEW YORK (Reuters Health) – A course of intravenous antibiotic therapy lasting no more than 3 days for hospitalized infants with urinary tract infections is just as successful…
NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement…
NEW YORK (Reuters Health) – In managing hospitalized patients who develop candidemia, the standard practice of promptly removing a central venous catheter does not improve outcomes, according a…
NEW YORK (Reuters Health) – Urinary tract infections occur quite often after patients are given detrusor injections of botulinum toxin A (BoNT-A) to reduce bladder overactivity, so prophylactic…
NEW YORK (Reuters Health) – First-line therapy with zidovudine and interferon-alpha improves overall survival in patients with adult T-cell leukemia/lymphoma (ATL), according to the results of a retrospective…
